Search

everythinglearnresearchcommunity

for

Search:↓

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Oxidative stress contributes to hair graying and loss as we age.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Fetal wound healing changes with development, affecting inflammation and collagen, which may influence scarring.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Topical JAK inhibitors may help treat some skin conditions but need more research.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.